Viridian Therapeutics Inc (VRDN) Return on Investment ROI from the first quarter of 2026 to first quarter of 2024 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Viridian Therapeutics Inc   (NASDAQ: VRDN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Viridian Therapeutics Inc's ROI from its first quarter of 2026 to the first quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Viridian Therapeutics Inc's ROI in the first quarter of 2026?
Viridian Therapeutics Inc recorded a cumulative net loss of $-371 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -54.54%.

Within the Healthcare sector 307 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2026 quarter, so far to 2201, from total ROI ranking in the fourth quarter of 2025 at 3320.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 5.54 % 14.1 % 34.24 % 53.49 % 78.14 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 737 829 526 627 694
Return On Investment (TTM) -54.54 % -51.66 % -43.12 % -47.43 % -41.91 %
VRDN's Overall Ranking # 2201 # 3320 # 1212 # 3555 #
Seq. Investment Change TTM 1.61 % 3.82 % -0.85 % 0.9 % 9.85 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -371 -346 -278 -308 -270

VRDN Company Profile >> Back to VRDN Roi Comparisons >> See Annual VRDN Return On Investment



Return On Investment VRDN's Ranking
Within: No.
Industry # 21
Sector # 308
Overall # 2201

Return On Investment Statistics
High Average Low
-41.88 %
-51.1 %
-65.62 %
(Dec 31 2024)   (Dec 31 2023)







Financial Statements
Viridian Therapeutics Inc's I. Quarter Investments $ 737 Millions VRDN's Balance sheet
Viridian Therapeutics Inc's I. Quarter Income $ -105 Millions Quarterly VRDN's Income Statement
VRDN's Income by Division See VRDN's Income by Division


VRDN Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 829 694 463 401 190
Y / Y Investment Growth 19.37 % 49.88 % 15.55 % 110.91 % 57.63 %
Net Income in Millions -343 -270 -238 -130 -79
Y / Y Net Income Growth - - - - -
Annual Return On Investment -41.34 % -38.88 % -51.32 % -32.4 % -41.78 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VRDN's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VRDN's Competitors
Subscribers only: Roi for Viridian Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for VRDN's Customers

Other Ratios
VRDN's Roa VRDN's Inventory Turnover Ratio VRDN's Growth Rates VRDN's Dividend Statistics
VRDN's Profitability Ratios VRDN's Asset Turnover Ratio VRDN's Dividend Growth
VRDN's Roe VRDN's Valuation Ratios VRDN's Financial Strength Ratios VRDN's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.